Occurrence/NN
of/IN
a/DT
silencer/NN
of/IN
the/DT
interleukin-2/NN
gene/NN
in/IN
naive/JJ
but/CC
not/RB
in/IN
memory/NN
resting/VBG
T/NN
helper/NN
lymphocytes/NNS
./.

In/IN
the/DT
immune/JJ
system/NN
the/DT
first/JJ
activation/NN
of/IN
a/DT
naive/JJ
T/NN
cell/NN
by/IN
antigen/NN
is/VBZ
a/DT
key/JJ
step/NN
in/IN
the/DT
shaping/NN
of/IN
the/DT
peripheral/JJ
T/NN
cell/NN
specificity/NN
repertoire/NN
and/CC
maintenance/NN
of/IN
self-tolerance/NN
./.
=====
In/IN
the/DT
present/JJ
study/NN
,/,
analysis/NN
of/IN
the/DT
interleukin-2/NN
(/(
IL-2/NN
)/)
gene/NN
activation/NN
shows/VBZ
that/IN
naive/JJ
human/JJ
helper/NN
T/NN
cells/NNS
(/(
cord/NN
blood/NN
CD4+/JJ
T/NN
cells/NNS
,/,
adult/JJ
CD4+CD45RO-/JJ
T/NN
cells/NNS
)/)
regulate/VBP
IL-2/NN
transcription/NN
by/IN
a/DT
mechanism/NN
involving/VBG
both/CC
a/DT
silencer/NN
and/CC
an/DT
activator/NN
acting/VBG
on/IN
the/DT
purine-rich/JJ
IL-2/NN
promoter/NN
elements/NNS
(/(
NF-AT/NN
binding/NN
sites/NNS
)/)
./.
=====
By/IN
contrast/NN
,/,
memory/NN
cells/NNS
,/,
either/CC
in/FW
vitro/FW
activated/VBN
helper/NN
T/NN
cells/NNS
reverting/VBG
to/TO
a/DT
resting/JJ
state/NN
,/,
or/CC
CD4+/JJ
T/NN
(/(
memory/NN
)/)
clones/NNS
,/,
or/CC
CD4+CD45RO+/JJ
T/NN
cells/NNS
isolated/VBN
ex/FW
vivo/FW
,/,
no/RB
longer/RB
have/VBP
a/DT
silencer/NN
./.
=====
Their/PRP$
IL-2/NN
transcription/NN
seems/VBZ
to/TO
be/VB
controlled/VBN
solely/RB
by/IN
the/DT
transition/NN
from/IN
inactive/JJ
to/TO
active/JJ
functional/JJ
state/NN
of/IN
a/DT
positive/JJ
transcription/NN
factor/NN
binding/VBG
to/TO
these/DT
promoter/NN
elements/NNS
as/RB
well/RB
as/IN
its/PRP$
cytoplasmic/JJ
or/CC
nuclear/JJ
location/NN
:/:
in/IN
resting/VBG
memory/NN
T/NN
cells/NNS
the/DT
activator/NN
is/VBZ
located/JJ
in/IN
the/DT
cytoplasm/NN
and/CC
is/VBZ
inactive/JJ
,/,
whereas/IN
in/IN
stimulated/VBN
cells/NNS
it/PRP
is/VBZ
functional/JJ
in/IN
promoting/VBG
transcription/NN
and/CC
now/RB
resides/VBZ
in/IN
the/DT
nucleus/NN
./.
=====
Thus/RB
,/,
the/DT
regulation/NN
of/IN
the/DT
gene/NN
coding/VBG
for/IN
the/DT
main/JJ
T/NN
cell/NN
growth/NN
factor/NN
changes/VBZ
irreversibly/RB
after/IN
the/DT
first/JJ
encounter/NN
of/IN
T/NN
cells/NNS
with/IN
antigen/NN
./.
=====
It/PRP
is/VBZ
most/RBS
likely/JJ
that/IN
the/DT
presence/NN
of/IN
a/DT
silencer/NN
contributes/VBZ
to/TO
the/DT
more/RBR
stringent/JJ
activation/NN
requirements/NNS
of/IN
naive/JJ
CD4+/JJ
T/NN
cells/NNS
./.